Analystreport

Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target lowered by analysts at Craig Hallum from $15.50 to $12.00. They now have a "buy" rating on the stock.

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com